Oncology Developer Yahong Bags China’s First Biotech IPO Of 2022

Active Funding Ahead Of Lunar New Year

 
• By Dexter Jie Yan
  
fund raising
VC/PE funds continued pumping fresh funds into Chinese biotechs despite sluggish performance of publicly traded companies • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia